cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.3535/t73-w6w-w90
title: Unionidae Rafinesque, 1820

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/b2e-rnm-tev
title: Cerion magister Pilsbry & Vanatta, 1896

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/r86-ca3-px2
title: Conus ebraeus Linnaeus, 1758

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/1wt-7jg-whv
title: Marmorana signata tetrazona (De Cristofori & Jan, 1832)

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/g8f-94b-trk
title: Conus garciai da Motta, 1982

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/6f6-8e3-r2j
title: Cochlicella acuta (O. F. Müller, 1774)

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/stw-rmq-xhm
title: Iberellus balearicus (Rossmässler, 1838)

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/kfz-nvx-5s3
title: Xerosecta terverii (Michaud, 1831)

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/atc-spy-npx
title: Unio crassus Philipsson, 1788

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/lcg-pzc-ahq
title: Ostreidae Rafinesque, 1815

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/q62-vl4-hcl
title: Tucetona pectinata (Gmelin, 1791)

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/zv3-gt4-y9l
title: Atrina vexillum (Born, 1778)

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/bac-h4p-6q2
title: Philalanka thienemanni B. Rensch, 1932

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/rkv-51j-et7
title: Conus emaciatus Reeve, 1849

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/3yq-c76-3vc
title: Corilla humberti (Brot, 1864)

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/30q-1rx-avv
title: Tanychlamys amboinensis (E. von Martens, 1864)

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/9h6-1b4-6pz
title: Webbhelix multilineata (Say, 1821)

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/1ss-x5x-7k3
title: Metafruticicola pellita (A. Férussac, 1832)

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/b86-bb8-amj
title: Aegopinella nitens (Michaud, 1831)

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/bdm-x6t-xa1
title: Cornu aspersum (O. F. Müller, 1774)

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/1p4-fk7-tyn
title: Helicella itala (Linnaeus, 1758)

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/z3h-deg-g2r
title: Succinea undulata Say, 1829

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/dsc-f2f-29y
title: Succinea lauta A. Gould, 1859

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/jsm-b5x-7dk
title: Cepaea nemoralis (Linnaeus, 1758)

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/9m5-0sr-h57
title: Conus catus Hwass, 1792

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/al1-6hn-g98
title: Lens contradens (I. Lea, 1838)

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/d3m-ldg-9rb
title: Caribachlamys ornata (Lamarck, 1819)

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/9nt-5bl-rq6
title: Tucetona pectunculus (Linnaeus, 1758)

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/c1n-2w1-27s
title: Metafruticicola pellita (A. Férussac, 1832)

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/88p-grm-y2e
title: Jolya elongata (Swainson, 1821)

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/lmt-ka6-qqg
title: Bradybaena fuchsi (Gredler, 1878)

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/s62-vj6-52t
title: Conus distans Hwass, 1792

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/y6q-dx6-wcj
title: Chloritis helicinoides (Mousson, 1849)

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/wj6-fmr-hc0
title: Cornu aspersum (O. F. Müller, 1774)

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/x4m-ss9-btd
title: Helicidae Rafinesque, 1815

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/9ls-dv1-s1n
title: Lamprocystis gedeana Möllendorff, 1897

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/mxt-pew-rrk
title: Acar rostae (S. S. Berry, 1954)

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/gax-dcz-v30
title: Limea crassa (Forbes, 1844)

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/l0c-s11-d6k
title: Cerion Röding, 1798

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/vsz-yve-l8k
title: Nautilus pompilius Linnaeus, 1758

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/vzp-szy-zk2
title: Brachypodella hanleyana (L. Pfeiffer, 1847)

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/q50-kwe-m44
title: Cornu aspersum (O. F. Müller, 1774)

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/0c7-znj-tc1
title: Spirula spirula (Linnaeus, 1758)

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/adn-pb5-azg
title: Sphincterochila candidissima (Draparnaud, 1801)

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/wt8-hje-als
title: Ostrea edulis Linnaeus, 1758

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.5281/zenodo.16838697
title: ResearchData_Chen_et_al
DOI: 10.5281/zenodo.16838698
title: ResearchData_Chen_et_al
DOI: 10.3535/0z2-1kl-pd2
title: Ostreidae Rafinesque, 1815

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/5jm-j5e-6nx
title: Anodontia alba Link, 1807

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.6084/m9.figshare.29900168
title: Supplementary Material for: Impact of antibiotic therapy in patients with cholangiocarcinoma treated with chemoimmunotherapy

description: Background: Patients with biliary tract cancers (BTC) often require antibiotic therapy before starting systemic treatment that includes an immune checkpoint inhibitor. This study aims to evaluate the prognostic impact of antibiotic therapy administered in the 15 days prior to the start of chemoimmunotherapy in patients with BTC.
Material and methods: The study population included patients with metastatic or locally advanced BTC from western and eastern populations treated with first-line chemoimmunotherapy. The aim of the study is to evaluate the impact of antibiotic therapy in the 15 days prior to starting oncological treatment (AT population) compared to patients who did not receive antibiotic therapy (NAT). Univariate and multivariate analyses were used to evaluate predictive factors for overall survival (OS) and progression free survival (PFS) while prognostic factors were analyzed by univariate and multivariate analysis using Cox regression model.
Results: 666 patients were enrolled in the study: 93 (14%) in AT cohort and 573 (86%) in NAT cohort. In the AT population, the incidence of cholangitis (p = 0.0017), ALT elevation (p = 0.0009), fever (p = 0.0021), decreased appetite (p = 0.0007), itching (p = 0.0081), and rash (p = 0.012) was significantly higher compared to the NAT. 
The median OS was 15.9 months (95% CI 13.8 - 18.3) in NAT cohort vs 10.1 months (95% CI 7.9 - 12.4) in AT cohort (NAT vs AT, HR 0.43,95% CI 0.27 – 0.70-15.6 p=0.0006) while median PFS was 8.5 months in NAT cohort vs 5.4 months in AT cohort (NAT vs AT, HR 0.49 ,95% CI 0.34 - 0.71 p=0.0001). Multivariate analysis confirmed the prognostic role of antibiotic for OS and PFS. Finally, NAT cohort showed better overall response rate compared with AT cohort (31.4% vs 20.4 %, p=0.03). 
Conclusions: 
The use of antibiotic therapy in the 15 days prior to starting chemoimmunotherapy is an independent unfavorable prognostic factor for survival in our cohort of patients with advanced BTC treated with cisplatin, gemcitabine and durvalumab
DOI: 10.6084/m9.figshare.29900168.v1
title: Supplementary Material for: Impact of antibiotic therapy in patients with cholangiocarcinoma treated with chemoimmunotherapy

description: Background: Patients with biliary tract cancers (BTC) often require antibiotic therapy before starting systemic treatment that includes an immune checkpoint inhibitor. This study aims to evaluate the prognostic impact of antibiotic therapy administered in the 15 days prior to the start of chemoimmunotherapy in patients with BTC.
Material and methods: The study population included patients with metastatic or locally advanced BTC from western and eastern populations treated with first-line chemoimmunotherapy. The aim of the study is to evaluate the impact of antibiotic therapy in the 15 days prior to starting oncological treatment (AT population) compared to patients who did not receive antibiotic therapy (NAT). Univariate and multivariate analyses were used to evaluate predictive factors for overall survival (OS) and progression free survival (PFS) while prognostic factors were analyzed by univariate and multivariate analysis using Cox regression model.
Results: 666 patients were enrolled in the study: 93 (14%) in AT cohort and 573 (86%) in NAT cohort. In the AT population, the incidence of cholangitis (p = 0.0017), ALT elevation (p = 0.0009), fever (p = 0.0021), decreased appetite (p = 0.0007), itching (p = 0.0081), and rash (p = 0.012) was significantly higher compared to the NAT. 
The median OS was 15.9 months (95% CI 13.8 - 18.3) in NAT cohort vs 10.1 months (95% CI 7.9 - 12.4) in AT cohort (NAT vs AT, HR 0.43,95% CI 0.27 – 0.70-15.6 p=0.0006) while median PFS was 8.5 months in NAT cohort vs 5.4 months in AT cohort (NAT vs AT, HR 0.49 ,95% CI 0.34 - 0.71 p=0.0001). Multivariate analysis confirmed the prognostic role of antibiotic for OS and PFS. Finally, NAT cohort showed better overall response rate compared with AT cohort (31.4% vs 20.4 %, p=0.03). 
Conclusions: 
The use of antibiotic therapy in the 15 days prior to starting chemoimmunotherapy is an independent unfavorable prognostic factor for survival in our cohort of patients with advanced BTC treated with cisplatin, gemcitabine and durvalumab
DOI: 10.3535/hk3-dzt-5we
title: Conus boeticus Reeve, 1844

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/st2-0bm-dw1
title: Rumina decollata (Linnaeus, 1758)

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/xhs-hty-mhd
title: Cerion abacoense Pilsbry & Vanatta, 1895

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/2jr-p7j-1wb
title: Helicodonta obvoluta (O. F. Müller, 1774)

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/rq0-z9s-cy4
title: Xerosecta contermina (L. Pfeiffer, 1848)

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.6084/m9.figshare.29900171
title: Supplementary Material for: Real-World Insights into Avatrombopag’s Effectiveness and Safety in Adults with Primary Immune Thrombocytopenia: A Retrospective Analysis from Central and Eastern Europe

description: Introduction: Primary immune thrombocytopenia (ITP) is an autoimmune condition marked by low platelet counts, leading to symptoms such as bleeding. Avatrombopag (AVA), a second-generation thrombopoietin receptor agonist (TPO-RA), has shown efficacy in clinical trials but lacks extensive real-world data, particularly in Central and Eastern Europe (CEE).
Objective: This study aims to evaluate the effectiveness and safety of AVA in routine clinical practice for ITP patients across CEE countries.
Methods: A multicentre, non-interventional, retrospective analysis was conducted in Slovenia, Croatia and the Czech Republic, involving 41 patients treated with AVA for primary ITP. The primary endpoint was achieving a platelet response at Week 8.
Results: AVA treatment resulted in a 68.3% platelet response rate by Week 8, with a significant increase in median platelet counts. Rescue medication use decreased post-AVA initiation, and many patients reduced or discontinued steroids. AVA was well-tolerated, with only one adverse event reported and no significant bleeding events.
Conclusion: AVA is effective in improving platelet counts and reducing medication dependency in ITP patients in CEE countries. It offers a viable treatment option with a favourable safety profile, supporting its use across different ITP stages and patient demographics.
DOI: 10.6084/m9.figshare.29900171.v1
title: Supplementary Material for: Real-World Insights into Avatrombopag’s Effectiveness and Safety in Adults with Primary Immune Thrombocytopenia: A Retrospective Analysis from Central and Eastern Europe

description: Introduction: Primary immune thrombocytopenia (ITP) is an autoimmune condition marked by low platelet counts, leading to symptoms such as bleeding. Avatrombopag (AVA), a second-generation thrombopoietin receptor agonist (TPO-RA), has shown efficacy in clinical trials but lacks extensive real-world data, particularly in Central and Eastern Europe (CEE).
Objective: This study aims to evaluate the effectiveness and safety of AVA in routine clinical practice for ITP patients across CEE countries.
Methods: A multicentre, non-interventional, retrospective analysis was conducted in Slovenia, Croatia and the Czech Republic, involving 41 patients treated with AVA for primary ITP. The primary endpoint was achieving a platelet response at Week 8.
Results: AVA treatment resulted in a 68.3% platelet response rate by Week 8, with a significant increase in median platelet counts. Rescue medication use decreased post-AVA initiation, and many patients reduced or discontinued steroids. AVA was well-tolerated, with only one adverse event reported and no significant bleeding events.
Conclusion: AVA is effective in improving platelet counts and reducing medication dependency in ITP patients in CEE countries. It offers a viable treatment option with a favourable safety profile, supporting its use across different ITP stages and patient demographics.
DOI: 10.3535/2w7-cvw-lcl
title: Arca zebra Swainson, 1833

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/0yv-9q9-hrd
title: Glycymeris undata (Linnaeus, 1758)

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/gt4-nzg-fas
title: Nautilus pompilius Linnaeus, 1758

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.6084/m9.figshare.29900174
title: Supplementary Material for: An Unusual Compulsive Behavior Related to Scalp Psoriasis and Hair Follicle Anxiety in Young Men

description: Introduction: Patients suffering from androgenetic alopecia may experience obsessive behaviors on observing their own scalp.
Case Presentation: This article describes a series of three cases of young men presenting with an unusual, seemingly compulsive behavior related to mild scalp psoriasis and a family history of androgenetic alopecia. Contrary to the typical goal of psoriasis treatment, these patients exhibit an intense fixation on scalp scales containing embedded hairs. They actively avoid dislodging these scales during routine hygiene or therapeutic efforts, fearing that their removal might accelerate hair loss. The cases involve young men (aged 24, 19, and 22) with significant anxiety about hair loss, which manifests as a meticulous and repetitive manipulation of their scalps to preserve these specific scales. 
Conclusion: This behavior may fall within the spectrum of body-focused repetitive behaviors (BFRBs). This observation underscores the importance for dermatologists to thoroughly question patients about underlying anxieties and specific scalp manipulation behaviors, especially in young men with a familial history of alopecia, to facilitate more effective clinical management.
DOI: 10.6084/m9.figshare.29900174.v1
title: Supplementary Material for: An Unusual Compulsive Behavior Related to Scalp Psoriasis and Hair Follicle Anxiety in Young Men

description: Introduction: Patients suffering from androgenetic alopecia may experience obsessive behaviors on observing their own scalp.
Case Presentation: This article describes a series of three cases of young men presenting with an unusual, seemingly compulsive behavior related to mild scalp psoriasis and a family history of androgenetic alopecia. Contrary to the typical goal of psoriasis treatment, these patients exhibit an intense fixation on scalp scales containing embedded hairs. They actively avoid dislodging these scales during routine hygiene or therapeutic efforts, fearing that their removal might accelerate hair loss. The cases involve young men (aged 24, 19, and 22) with significant anxiety about hair loss, which manifests as a meticulous and repetitive manipulation of their scalps to preserve these specific scales. 
Conclusion: This behavior may fall within the spectrum of body-focused repetitive behaviors (BFRBs). This observation underscores the importance for dermatologists to thoroughly question patients about underlying anxieties and specific scalp manipulation behaviors, especially in young men with a familial history of alopecia, to facilitate more effective clinical management.
DOI: 10.3535/h15-ar7-h2q
title: Pararyssota quadrasi (Hidalgo, 1887)

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/r4b-g5z-wyr
title: Oxychilus Fitzinger, 1833

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/zqw-w1s-r7l
title: Cornu aspersum (O. F. Müller, 1774)

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.6084/m9.figshare.29900177
title: Supplementary Material for: Safety and Efficacy of Givinostat for patients with Muscular dystrophy: A Systematic review

description: Introduction: Muscular dystrophy(MD) refers to a group of genetic disorders leading to progressive weakness and degeneration of skeletal muscle. Among them, Duchenne muscular dystrophy(DMD) and Becker muscular dystrophy(BMD) are the most common types. Histone deacetylase(HDAC) inhibitors(i.e. Givinostat) are a recently approved therapy for DMD. In this systematic review, we aim to evaluate Givinostat in MD patients regarding safety and efficacy.
Methods: A systematic review was performed according to the PRISMA guidelines by searching through Medline, Embase, Cochrane Library and Web of Science. Only RCT comparing Givinostat vs placebo or other therapies are included. The primary outcomes were motor function alteration and histopathologic muscle changes and the secondary outcomes were the adverse reactions.
Results: A total of 188 records were identified, and after screening, two clinical trials met the inclusion criteria. In DMD patients, Givinostat significantly slowed disease progression, improving four stair-climb times (p=0.037) and reducing muscle fat infiltration. In BMD patients, fibrosis progression was not significantly different (p=0.8282), but MRI showed reduced muscle fat replacement. Common adverse events included diarrhea, thrombocytopenia, and hypertriglyceridemia, leading to dose reductions, though no new safety signals or treatment-related deaths were observed.
Discussion: Givinostat seems to be effective in slowing disease progression in DMD but has little benefit in BMD. Its safety profile requires rigorous monitoring. Efficacy difference might be explained by the pathophysiology of the disease and the progression rate. Larger and longer follow-up trials are warranted to confirm longer term benefits and to optimize dosing strategies.
Conclusion: Givinostat offers potential as a disease-modifying therapy for DMD but requires further investigation to establish its role in BMD.
DOI: 10.3535/rez-7k2-htq
title: Laevichlamys squamosa (Gmelin, 1791)

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/ya4-jc6-sbn
title: Xeromunda candiota (L. Pfeiffer, 1849)

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.